WHALEN, John, CHANDRA, Anita, KRACKER, Sven, EHL, Stephan, SEIDEL, Markus G., GULAS, Ioana, DRON, Louis, VELUMMAILUM, Russanthy, NAGAMUTHU, Chenthila, LIU, Sichen, TUTEIN NOLTHENIUS, Joanne, MACCARI, Maria Elena, GRIMBACHER, Bodo, KINDLE, Gerhard und SPECKMANN, Carsten, 2025. Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (Ig M) levels among individuals with activated phosphoinositide 3-kinase delta (PI3 Kδ) syndrome (APDS): an externally controlled study : = Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (Ig M) levels among individuals with activated phosphoinositide 3-kinase delta (PI3 K[delta]) syndrome (APDS): an externally controlled study. Freiburg: Universität.

Whalen, J., Chandra, A., Kracker, S., Ehl, S., Seidel, M.G., Gulas, I., Dron, L., Velummailum, R., Nagamuthu, C., Liu, S., Tutein Nolthenius, J., Maccari, M.E., Grimbacher, B., Kindle, G., Speckmann, C., 2025. Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (Ig M) levels among individuals with activated phosphoinositide 3-kinase delta (PI3 Kδ) syndrome (APDS): an externally controlled study : = Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (Ig M) levels among individuals with activated phosphoinositide 3-kinase delta (PI3 K[delta]) syndrome (APDS): an externally controlled study. Universität, Freiburg. https://doi.org/10.1093/cei/uxae107

Whalen, J., Chandra, A., Kracker, S., Ehl, S., Seidel, M. G., Gulas, I., Dron, L., Velummailum, R., Nagamuthu, C., Liu, S., Tutein Nolthenius, J., Maccari, M. E., Grimbacher, B., Kindle, G., & Speckmann, C. (ca. 2025). Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (Ig M) levels among individuals with activated phosphoinositide 3-kinase delta (PI3 Kδ) syndrome (APDS): an externally controlled study : = Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (Ig M) levels among individuals with activated phosphoinositide 3-kinase delta (PI3 K[delta]) syndrome (APDS): an externally controlled study [Cd]. Universität. https://doi.org/10.1093/cei/uxae107

Whalen J, Chandra A, Kracker S, Ehl S, Seidel MG, Gulas I, Dron L, Velummailum R, Nagamuthu C, Liu S, Tutein Nolthenius J, Maccari ME, Grimbacher B, Kindle G, Speckmann C (2025) Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (Ig M) levels among individuals with activated phosphoinositide 3-kinase delta (PI3 Kδ) syndrome (APDS): an externally controlled study : = Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (Ig M) levels among individuals with activated phosphoinositide 3-kinase delta (PI3 K[delta]) syndrome (APDS): an externally controlled study. Universität, Freiburg

Whalen, John/ Chandra, Anita/ Kracker, Sven/ Ehl, Stephan/ Seidel, Markus G./ Gulas, Ioana/ Dron, Louis/ Velummailum, Russanthy/ Nagamuthu, Chenthila/ Liu, Sichen/ Tutein Nolthenius, Joanne/ Maccari, Maria Elena/ Grimbacher, Bodo/ Kindle, Gerhard/ Speckmann, Carsten, Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (Ig M) levels among individuals with activated phosphoinositide 3-kinase delta (PI3 Kδ) syndrome (APDS): an externally controlled study : = Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (Ig M) levels among individuals with activated phosphoinositide 3-kinase delta (PI3 K[delta]) syndrome (APDS): an externally controlled study, Freiburg 2025.